Heterologous
collagen-preserved
bone graft
The best alternative to autologous bone
Osteoxenon® is the heterologous bone graft with preserved collagen and unaltered mineral component that most closely resembles autologous bone in its physical and biological features. Native collagen preserved within Osteoxenon® (type I collagen) enhances the natural bone remodeling process within the graft site.
PROPERTIES
-
SUPERIOR
QUALITY RAW
MATERIAL -
ENZYMATIC
DEANTIGENATION -
UNALTERED
MINERAL
PHASE -
PRESERVED
COLLAGEN -
BETA RAY
STERILIZATION
BENEFITS
-
IT IS MORE
NATURAL -
INCREASED
PREDICTABILITY
OF RESULTS -
IT ACCELERATES
HEALING
For uncompromising regeneration
The unique remodeling, mechanical strength and elasticity features of Osteoxenon® products allow even the most complex clinical cases to be addressed with the confidence of using a material that promotes natural tissue regeneration.
WIDE RANGE
GRANULES • GRANULES IN SYRINGE • BLOCKS • FLEX CORTICAL SHEET • FLEX CANCELLOUS SHEET
OSTEOXENON® THE BONE GRAFT
THAT ENHANCES NATURE
THE NATURAL SCAFFOLD
a) Optical microscope image of Osteoxenon® bone graft trabeculae.
b) The same image, visualized with polarized light, shows the preservation of collagen fibers in pink.
PHYSIOLOGICAL RECOGNITION
Osteoclasts (OCLs) physiologically adhere to both natural, untreated bone (a) and Osteoxenon® bone graft obtained by the Zymo-Teck enzymatic deantigenation process (b).
Insights
Clinical and histological evidence
Histological studies show that the use of Osteoxenon® promotes the apposition of high amounts of new bone tissue within the site with progressive replacement of the biomaterial with viable bone within a physiological time frame.
Sinus lift
Comparison of % neoformed bone and % residual biomaterial for Osteoxenon®, Bio-Gen® and Anorganic Bovine Bone (ABB) in sinus lift at 6 months. Note how Osteoxenon® has the % of neoformed bone almost twice as high as ABB and the % of residual biomaterial about 1/3 as ABB and Bio-Gen ®.
Post-extractive socket
Comparison of % newly formed bone and % residual biomaterial for Osteoxenon®, Bio-Gen®, and Bovine Bone Anorganic (ABB) in the post-extractive socket at 4.5 months. Note how Osteoxenon® has the highest % of neoformed bone, almost double that of ABB, while the % of residual biomaterial is about half that of ABB.
The entire range
OSTEOXENON®
Granules
| OSP-OX30 | Cancellous Granules – 1 btl / 0.5g ~1cc 0.25-1mm |
| OSP-OX31 | Cancellous Cortical Granules – 1 btl / 0.5g ~1cc 0.25-1mm |
| OSP-OX32 | Cancellous Cortical Granules – 1 btl / 1g ~2cc 0.25-1mm |
| OSP-OX33 | Cancellous Granules – 1 btl / 2cc 2-3mm |
| OSP-OX34 | Cancellous Granules – 1 btl / 1g ~2cc 2-4mm |
| OSP-OX35 | Cancellous Cortical Granules – 1 btl / 0.25g ~0.5cc 0.25-1 mm |
| OSP-OX36 | Cancellous Granules – 1 btl / 1g ~2cc 0.25-1mm |
| OSP-OX37 | Cancellous Granules – 1 btl / 0.25g ~0.5cc 0.25-1 mm |
| OSP-OX38 | Cancellous Granules – 1 btl / 2g ~4cc 0.25-1mm |
| OSP-OX39 | Cancellous Granules – 1 btl / 4cc 2-3mm |
| OSP-OX40 | Cortical Granules – 1 btl / 0.5g ~1cc. 0.25-1 mm |
| OSP-OX41 | Cancellous Cortical Granules – 1 btl / 2g ~4cc 0.25-1mm |
| OSP-OX50 | Cancellous Granules – 1 btl / 0.5g ~1cc 1-2mm |
| OSP-OX66 | Cancellous Granules – 1 btl / 1g ~2cc 1-2mm |
OSTEOXENON®
Gel Granules
| OSP-OX21n | Cancellous Cortical Gel – 1 syr / 0.25 ml |
| OSP-OX22n | Cancellous Cortical Gel – 1 syr / 0.5 ml |
| OSP-OX23 | Cancellous Cortical Gel – 1 syr / 1 ml |
OSTEOXENON®
Flex
| OSP-OX01 | Flex Cancellous sheet – 1 pc 25 x 25 x 3 mm |
| OSP-OX08 | Flex Cortical Sheet- 1 pc 21-25 x 23-27 x 0.9 mm |
| OSP-OX09 | Flex Cortical Sheet- 1 pc 21-25 x 23-27 x 0.5 mm |
| OSP-OX03 | Flex Cortical sheet – 1 pc 21-25 x 23-27 x 0.2 mm |
OSTEOXENON®
Cancellous Blocks
| OSP-OX51 | Cancellous Block – 1 pc 10 x 10 x 10 mm |
| OSP-OX52 | Cancellous Block – 1 pc 10 x 10 x 20 mm |
| OSP-OX54n | Cancellous Block – 1 pc 10 x 20 x 3 mm |
| OSP-OX55n | Cancellous Block – 1 pc 10 x 20 x 5 mm |
YOU CAN STILL DONATE BLOOD
Patients treated with all Bioteck medical devices remain suitable for the donation
of blood or blood components, as stated in current legislation.
